-
Meitheal Pharmaceuticals releases generic Abraxane
03 Jun 2025 22:59 GMT
… is a generic form of Abraxane.
The 100mg/vial single … or metastatic non-small cell lung cancer.
[Read more: Meitheal intros 2 …
-
Cipla receives USFDA approval for Generic Abraxane
11 Apr 2025 05:07 GMT
… of Bristol Myers Squibb’s Abraxane® in the United States.
Cipla … is a therapeutic equivalent to Abraxane®, a widely used chemotherapy drug … or metastatic non-small cell lung cancer (NSCLC), and metastatic adenocarcinoma of …
-
Do Oncology Board Exams Make Us Better Doctors?
10 Jul 2025 17:23 GMT
… on first-line gemcitabine plus abraxane. The question asks exam takers … a few others.
For nonsquamous lung cancer, cisplatin plus pemetrexed is preferred … pemetrexed.
For KRAS G12C-mutated lung cancer, sotorasib is recommended as a …
-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… worse and survival. In contrast, Abraxane was more effective than conventional … metastatic adenocarcinoma of the pancreas, Abraxane was shown to improve overall … non-small cell lung cancer, 33% of patients receiving Abraxane and carboplatin responded …
-
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
31 Jul 2024 22:56 GMT
… ;s and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed … cancer and non-small cell lung cancer (NSCLC), as well as a …
-
Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
14 Nov 2024 09:57 GMT
… cell lung cancer, and pancreatic carcinoma.6–8
Abraxane was … the analysis specifically targeted Abraxane-related effects.
Results … understand their association with Abraxane. Overall, these … -squamous non-small-cell lung cancer (IMpower130): a multicentre, …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
-
Platelet Membrane-Coated Poly (Lactic-Co-Glycolic Acid) Nanoparticles as a Targeting Drug Delivery System for Multidrug-Resistant Breast Cancer
01 Jul 2025 22:18 GMT
… Although alternative formulations such as Abraxane® (albumin-bound PTX) and Genexol … tetrandrine nanoparticles in nonsmall cell lung cancer. Mol Pharm. 2023;20(11 …
-
FDA approves new Bristol Myers drug for lung cancer
16 Nov 2023 21:00 GMT
… Myers Squibb’s new lung cancer medication Augtyro, which the … with non-small cell lung cancer have this alteration, and … Opdivo transformed the treatment of lung cancer. But for patients with … lived products like Revlimid, Abraxane and Eliquis hit or approach …
-
Emerging Trends in the Application of Nanosuspension-Based Biomaterials for Anticancer Drug Delivery
01 Jul 2025 12:03 GMT
… and human small-cell lung cancer. Paclitaxel-loaded nanosuspensions … based systems, such as Abraxane® (Paclitaxel albumin-bound … treatment of breast and lung cancers, demonstrating improved drug … for treatment of lung cancer. Lung Cancer Pers Med Nov Ther …
About
© 1995-2025